UNITED STATES OF AMERICA

Agency decision

Ask Donna

What actually matters in this document.

Text

UNITED STATES OF AMERICA

Before the

SECURITIES AND EXCHANGE COMMISSION

SECURITIES EXCHANGE ACT OF 1934

Release No. 101756 / November 26, 2024

ADMINISTRATIVE PROCEEDING

File No. 3-20945

In the Matter of

Surgalign Holdings, Inc. and

Robert P. Jordheim,

Respondents.

:

:

:

:

:

:

:

NOTICE OF PROPOSED PLAN OF

DISTRIBUTION AND

OPPORTUNITY FOR COMMENT

Notice is hereby given, pursuant to Rule 1103 of the United States Securities and

Exchange Commission’s (“Commission”) Rules on Fair Fund and Disgorgement Plans (the

“Commission’s Rules”), 17 C.F.R. § 201.1103, that the Division of Enforcement has submitted

to the Commission a proposed plan of distribution (the “Proposed Plan”) for the distribution of

monies collected in the above-captioned matter.

On August 3, 2022, the Commission issued an Order Instituting Public Administrative

and Cease-and-Desist Proceedings Pursuant to Section 8A of the Securities Act of 1933, Sections

4C and 21C of the Securities Exchange Act of 1934, and Rule 102(e) of the Commission's Rules

of Practice, Making Findings, and Imposing Remedial Sanctions and a Cease-and-Desist Order

(the “Order”)1 against Surgalign Holdings, Inc. (formerly known as RTI Surgical Holdings, Inc.

and RTI Surgical, Inc.) (“Surgalign”) and Robert P. Jordheim (“Jordheim”) (collectively, the

“Respondents”). In the Order, the Commission found that from 2015 through 2019, Surgalign

shipped orders weeks or months before its customers had originally requested delivery, thereby

pulling sales forward from future quarters, to address projected quarterly revenue shortfalls. In

some instances, Surgalign did so after requesting and obtaining customer permission; in other

instances, Surgalign shipped orders early without customer approval and then prematurely

recognized revenue for the sales. In multiple quarters, Surgalign would not have met its revenue

guidance without these undisclosed pull-forwards. Surgalign and its former senior management,

including Jordheim, did not disclose to investors that Surgalign’s apparent success at achieving

its revenue guidance resulted from its reliance on pull-forwards. Respondents also did not

disclose the known uncertainty that this practice created for Surgalign’s future revenue streams.

On March 16, 2020, Surgalign issued a press release stating that the Audit Committee of

Surgalign’s Board of Directors, with the assistance of independent legal and forensic accounting

1

Securities Act Rel. No. 11088 (Aug. 3, 2022).

advisors, was in the process of conducting an internal investigation of current and prior period

matters relating to Surgalign’s revenue recognition practices regarding the timing of revenue

with respect to certain contractual arrangements. The investigation primarily focused on

contractual arrangements with original equipment manufacturer customers, including the

accounting treatment, financial reporting and internal controls related to such arrangements.

On June 8, 2020, Surgalign issued a restatement to correct, among other things, its

premature recognition of revenue, in violation of generally accepted accounting principles

(GAAP), for orders shipped early to customers without their approval for the fiscal years ended

December 31, 2016, 2017 and 2018, selected financial data for the years ended December 31,

2014 and 2015, and related disclosures for the quarterly periods for such years, each on Form 10K/A, and restated condensed consolidated unaudited financial statements for the quarters ended

March 31, 2019, June 30, 2019, and September 30, 2019, reflected in its 2019 Form 10-K.

As a result of the conduct described in the Order, the Commission ordered the

Respondents to pay $2,075,000 in civil money penalties. In the Order, the Commission created a

Fair Fund pursuant to Section 308(a) of the Sarbanes-Oxley Act of 2002 so that the civil penalty

collected, can be distributed to harmed investors.

Respondents have paid the full amount of $2,075,000 into the Fair Fund. The Fair Fund

has been deposited in a Commission-designated account at the United States Department of the

Treasury, and any accrued interest will be added to the Fair Fund.

OPPORTUNITY FOR COMMENT

Pursuant to this Notice, all interested persons are advised that they may obtain a copy of

the Plan from the Commission’s public website at

https://www.sec.gov/litigation/fairfundlist.htm. Interested persons may also obtain a written

copy of the Proposed Plan by submitting a written request to Michael Lim, United States

Securities and Exchange Commission, 100 F Street, NE, Washington, DC 20549-5876. All

persons who desire to comment on the Proposed Plan may submit their comments, in writing, no

later than 30 days from the date of this Notice:

1.

to the Office of the Secretary, United States Securities and Exchange

Commission, 100 F Street, NE, Washington, DC 20549-1090;

2.

by using the Commission’s Internet comment form

(https://www.sec.gov/litigation/admin.shtml); or

3.

by sending an e-mail to rule-comments@sec.gov.

Comments submitted by email or via the Commission’s website should include “Administrative

Proceeding File No. 3-20945” in the subject line. Comments received will be publicly available.

Persons should submit only information they wish to make publicly available.

2

THE PROPOSED PLAN

The Net Available Fair Fund2 is comprised of the $2,075,000.00 in civil money penalties

paid by the Respondents, plus interest and income earned thereon, less taxes, fees, and expenses.

The Proposed Plan provides for the distribution of the Net Available Fair Fund to investors who

purchased or acquired the Security on April 23, 2015 through March 16, 2020, inclusive, due to

the misconduct of the Respondents described in the Order and suffered a Recognized Loss as

calculated by the methodology used in the Plan of Allocation in the Proposed Plan.

For the Commission, by the Division of Enforcement, pursuant to delegated authority.3

Vanessa A. Countryman

Secretary

2

All capitalized terms used herein but not defined shall have the same meanings ascribed to them in the Proposed

Plan.

3

17 C.F.R. § 200.30-4(a)(21)(iii).

3

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.